Indications for TACE

Indications for TACE

Chemoembolization is indicated in patients with liver-dominant hepatic malignancies who are not candidates for curative resection.

In patients with hepatocellular carcinoma (HCC), TACE has been used as palliative treatment or as a bridge to liver transplantation.

It is considered standard of care for intermediate stages of HCC according to the Barcelona Clinic Liver Cancer staging system.

TACE has also been used as a palliative treatment for patients with unresectable cholangiocarcinoma, and hepatic metastases from neuroendocrine tumors, colorectal carcinoma, breast carcinoma, as well as soft-tissue sarcomas.

The injection of the chemotherapeutic agent mixed with ethiodized oil followed by embolization with particles is considered conventional TACE as opposed to a more recent refinement of the technique using drug-eluting beads to both deliver the chemotherapy and act as the embolic agent.


Sign up to receive the trending updates and tons of Health Tips

Join SeekhealthZ and never miss the latest health information